IS7674A - Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði - Google Patents
Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíðiInfo
- Publication number
- IS7674A IS7674A IS7674A IS7674A IS7674A IS 7674 A IS7674 A IS 7674A IS 7674 A IS7674 A IS 7674A IS 7674 A IS7674 A IS 7674A IS 7674 A IS7674 A IS 7674A
- Authority
- IS
- Iceland
- Prior art keywords
- fluorobenzyl
- quinoxaline
- carbamoyl
- dihydroxy
- octyl
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 1
- YEQJVHQCUDMXFG-UHFFFAOYSA-N n-[5-carbamoyl-1-(3-fluorophenyl)-3,8-dihydroxy-8-methylnonan-2-yl]quinoxaline-2-carboxamide Chemical compound C=1N=C2C=CC=CC2=NC=1C(=O)NC(C(O)CC(CCC(C)(O)C)C(N)=O)CC1=CC=CC(F)=C1 YEQJVHQCUDMXFG-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40321602P | 2002-08-12 | 2002-08-12 | |
PCT/IB2003/003464 WO2004014875A1 (en) | 2002-08-12 | 2003-07-31 | Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amide |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7674A true IS7674A (is) | 2005-01-27 |
Family
ID=31715961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7674A IS7674A (is) | 2002-08-12 | 2005-01-27 | Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði |
Country Status (22)
Country | Link |
---|---|
US (1) | US20040072834A1 (is) |
EP (1) | EP1539715A1 (is) |
JP (1) | JP2005538130A (is) |
AP (1) | AP2005003226A0 (is) |
AR (1) | AR040839A1 (is) |
AU (1) | AU2003250450A1 (is) |
BR (1) | BR0313378A (is) |
CA (1) | CA2494776A1 (is) |
EC (1) | ECSP055588A (is) |
GT (1) | GT200300169A (is) |
IL (1) | IL166548A0 (is) |
IS (1) | IS7674A (is) |
MX (1) | MXPA05001781A (is) |
NO (1) | NO20050540L (is) |
OA (1) | OA12894A (is) |
PA (1) | PA8580401A1 (is) |
PE (1) | PE20040866A1 (is) |
TN (1) | TNSN05035A1 (is) |
TW (1) | TW200407316A (is) |
UY (1) | UY27928A1 (is) |
WO (1) | WO2004014875A1 (is) |
ZA (1) | ZA200500768B (is) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201130810A (en) | 2009-12-23 | 2011-09-16 | Ironwood Pharmaceuticals Inc | CRTH2 modulators |
US20130259830A1 (en) | 2010-07-12 | 2013-10-03 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
US20130216552A1 (en) | 2010-07-12 | 2013-08-22 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
CN102276539B (zh) * | 2011-06-29 | 2013-08-14 | 赵雪梅 | 一种具有抑菌作用的化合物及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE640616A (is) * | 1962-12-19 | |||
US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
CN1248968A (zh) * | 1997-02-26 | 2000-03-29 | 辉瑞大药厂 | 杂芳基-己酸酰胺衍生物、其制备方法及其作为MIP-1α与其CCRI受体结合的选择性抑制剂的用途 |
KR100385529B1 (ko) * | 1998-02-05 | 2003-05-27 | 화이자 프로덕츠 인코포레이티드 | 신규 디하이드록시헥산산 유도체 |
-
2003
- 2003-07-31 MX MXPA05001781A patent/MXPA05001781A/es not_active Application Discontinuation
- 2003-07-31 WO PCT/IB2003/003464 patent/WO2004014875A1/en not_active Application Discontinuation
- 2003-07-31 AP AP2005003226A patent/AP2005003226A0/xx unknown
- 2003-07-31 EP EP03784383A patent/EP1539715A1/en not_active Withdrawn
- 2003-07-31 JP JP2004527195A patent/JP2005538130A/ja active Pending
- 2003-07-31 OA OA1200500028A patent/OA12894A/en unknown
- 2003-07-31 BR BR0313378-8A patent/BR0313378A/pt not_active Application Discontinuation
- 2003-07-31 CA CA002494776A patent/CA2494776A1/en not_active Abandoned
- 2003-07-31 AU AU2003250450A patent/AU2003250450A1/en not_active Abandoned
- 2003-08-05 UY UY27928A patent/UY27928A1/es not_active Application Discontinuation
- 2003-08-06 GT GT200300169A patent/GT200300169A/es unknown
- 2003-08-06 TW TW092121503A patent/TW200407316A/zh unknown
- 2003-08-08 AR AR20030102881A patent/AR040839A1/es unknown
- 2003-08-08 PE PE2003000794A patent/PE20040866A1/es not_active Application Discontinuation
- 2003-08-08 US US10/637,475 patent/US20040072834A1/en not_active Abandoned
- 2003-08-12 PA PA20038580401A patent/PA8580401A1/es unknown
-
2005
- 2005-01-26 ZA ZA200500768A patent/ZA200500768B/xx unknown
- 2005-01-27 IS IS7674A patent/IS7674A/is unknown
- 2005-01-27 IL IL16654805A patent/IL166548A0/xx unknown
- 2005-01-31 NO NO20050540A patent/NO20050540L/no unknown
- 2005-02-03 EC EC2005005588A patent/ECSP055588A/es unknown
- 2005-02-11 TN TNP2005000035A patent/TNSN05035A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
US20040072834A1 (en) | 2004-04-15 |
AP2005003226A0 (en) | 2005-03-31 |
AR040839A1 (es) | 2005-04-20 |
MXPA05001781A (es) | 2005-04-25 |
PA8580401A1 (es) | 2004-02-16 |
IL166548A0 (en) | 2006-01-15 |
UY27928A1 (es) | 2004-03-31 |
OA12894A (en) | 2006-10-13 |
NO20050540L (no) | 2005-03-10 |
AU2003250450A1 (en) | 2004-02-25 |
WO2004014875A1 (en) | 2004-02-19 |
TW200407316A (en) | 2004-05-16 |
CA2494776A1 (en) | 2004-02-19 |
JP2005538130A (ja) | 2005-12-15 |
PE20040866A1 (es) | 2004-11-26 |
ZA200500768B (en) | 2006-07-26 |
ECSP055588A (es) | 2005-04-18 |
TNSN05035A1 (fr) | 2007-05-14 |
BR0313378A (pt) | 2005-07-12 |
EP1539715A1 (en) | 2005-06-15 |
GT200300169A (es) | 2004-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004025759D1 (de) | Synchronisierung von Datenkommunikation | |
DE60318920D1 (de) | Induktion von Insulin-produzierende Zellen | |
DK1490064T3 (da) | Substituerede pyridinoner som modulatorer af p38 MAP kinase | |
DK2508521T4 (da) | Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf | |
DK1529032T3 (da) | Fremgangsmåder til fremstilling af 4-4-4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)aminobenzonitrill | |
DE602005024336D1 (de) | Sendung von Nachbarnzellinformationen | |
DK1592401T3 (da) | Fremgangsmåde til ændring af medikamentkrystaldannelsen af mycophenolat-natriumsalt | |
DE602004028075D1 (de) | Endgerät mit Auflösung von Betriebsmittelkonflikten | |
DK1756049T3 (da) | Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater | |
ATE510556T1 (de) | Verwendung von erythropoietin | |
DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
DE60334261D1 (de) | Internet basierte Verwaltung von Bildersammlungen | |
DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
IS7674A (is) | Kristal form af kínoxalín-2-karboxýlsýru [4-karbamóýl-1-(3-flúrbensýl)-2,7-díhýdroxý-7-metýl-oktýl]-amíði | |
DE602004012925D1 (de) | Protokoll zur Erbringung von Diensten | |
DK1578731T3 (da) | Fremgangsmåde til fremstilling af pyrimidinforbindelser | |
DK1539746T3 (da) | N-substituerede 1H-indol-5-propionsyre-forbindelser som PPAR-agonister der er nyttige til behandling af diabetes | |
DK1519928T3 (da) | Fremgangsmåde til fremstilling af heterocykliske fluoralkenylsulfoner | |
DE602004023786D1 (de) | Herstellung von hochreinem Alkylgallium | |
DK1505992T3 (da) | Fremgangsmåde til reduktion af smerter ved hjælp af oncolytiske vira | |
DE602004027975D1 (de) | Herstellungsverfahren von Elektrodenpaste | |
IS6888A (is) | Aðferð við meðferð sykursýki af gerð I | |
DE60326321D1 (de) | Herstellungsverfahren von Farbstoffen | |
DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
DK1503995T3 (da) | Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer |